Skip to main content
Tianjin Ringpu Bio-Technology Co.,Ltd. logo

Tianjin Ringpu Bio-Technology Co.,Ltd. — Investor Relations & Filings

Ticker · 300119 ISIN · CNE100000TV1 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,284 across all filing types
Latest filing 2022-08-25 Interim / Quarterly Rep…
Country CN China
Listing Shenzhen Stock Exchange 300119

About Tianjin Ringpu Bio-Technology Co.,Ltd.

https://www.ringpu.com

Tianjin Ringpu Bio-Technology Co.,Ltd. is a high-tech enterprise specializing in the research, development, production, and sale of animal health products. The company offers a comprehensive portfolio that includes veterinary biological products, chemical drugs, feed additives, and pet health solutions. Its product range covers vaccines for poultry and livestock, as well as various pharmaceutical formulations such as injections, powders, and oral solutions. Ringpu Bio-Technology emphasizes innovation through its dedicated R&D centers, focusing on disease prevention and treatment to support the global animal husbandry industry. The company provides integrated health management services and high-quality veterinary medicines to ensure food safety and animal welfare.

Recent filings

Filing Released Lang Actions
中国银河证券股份有限公司关于天津瑞普生物技术股份有限公司2022年半年度跟踪报告
Interim / Quarterly Report Classification · 90% confidence The document is titled as a '2022 Half-Year Tracking Report' by China Galaxy Securities Co., Ltd. regarding Tianjin Ruipu Biotechnology Co., Ltd. It contains detailed information about the sponsor's review and supervision work, company governance, disclosure issues, and corrective measures taken during the half-year period. The content includes substantive financial and operational oversight details, but it is not a full financial report like an interim or annual report. Instead, it is a monitoring or tracking report by the sponsor on the company's compliance and governance during the half-year period. Given the nature of the document as a half-year tracking report with detailed sponsor oversight and company governance information, it fits best under the category of Interim / Quarterly Report (IR), which covers comprehensive financial or operational reports for periods shorter than a full fiscal year. Although the document length is under 5,000 characters, it contains substantive content and is not merely an announcement or certification. Therefore, the classification is IR with high confidence. H1 2022
2022-08-25 Chinese
关于董事会换届选举的公告
Board/Management Information Classification · 100% confidence The document is an announcement from Tianjin Ruipu Biotechnology Co., Ltd. regarding the re-election of the company's board of directors. It details the nomination and qualifications of candidates for the fifth board, the compliance with relevant laws and regulations, and the resignation of certain directors after the new board is formed. The document includes biographies of the nominated directors and independent directors. There is no financial data, earnings information, or regulatory filings related to financial performance. The content focuses exclusively on board changes and election procedures. Therefore, this document fits the category of Board/Management Information (MANG). The document length (5719 characters) supports it being a full announcement rather than a brief notice or report publication announcement.
2022-08-25 Chinese
独立董事候选人声明（周睿）
Board/Management Information Classification · 95% confidence The document is a formal declaration by an independent director candidate of Tianjin Ruipu Biotechnology Co., Ltd. It contains detailed statements about the candidate's qualifications, compliance with laws and regulations, and independence criteria. There is no financial data, no discussion of company performance, no voting results, no meeting materials, and no mention of report publication. The content is focused on board/management information, specifically the candidacy and qualifications of a board member. Therefore, the document fits best under the category of Board/Management Information (MANG). The document length is 3411 characters, which is consistent with a detailed declaration rather than a brief announcement or a full report.
2022-08-25 Chinese
2022年半年度报告披露提示性公告
Report Publication Announcement Classification · 100% confidence The document is very short (320 characters) and is an announcement stating that the company's 2022 half-year report has been disclosed on official websites. It does not contain the actual half-year financial report or substantive financial data, but rather directs investors to where the report can be found. This fits the pattern of a Report Publication Announcement (RPA) rather than the report itself (IR).
2022-08-25 Chinese
董事会决议公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of resolutions passed at the 42nd meeting of the 4th Board of Directors of Tianjin Ruipu Biotechnology Co., Ltd. It includes approval of the 2022 half-year report, nomination of candidates for the 5th Board of Directors, and plans for a shareholders meeting. The content focuses on board meeting decisions, board member nominations, and procedural compliance. There is no full financial report or detailed financial statements included, but rather board meeting resolutions and related governance matters. This fits the category of Board/Management Information (MANG), which covers announcements of changes in the company's board or senior management.
2022-08-25 Chinese
独立董事提名人声明（一）
Board/Management Information Classification · 100% confidence The document is a public statement from the board of directors nominating an independent director candidate for the company's board. It details the nominee's qualifications, compliance with various regulatory requirements, and confirms no conflicts or disqualifications. There are no financial statements, earnings data, or report attachments. The content is focused on board/management information specifically about director nomination. The document length is short (3504 characters) and it is not an announcement of a report publication but a direct statement regarding board management. Therefore, the appropriate classification is Board/Management Information (MANG).
2022-08-25 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.